Veterans Affairs will cover pricey experimental Alzheimer's drug
The Veterans Health Administration (VHA) said it will widely cover an experimental $26,500-per-year Alzheimer’s drug, even though Medicare will not. Leqembi will be made available to veterans living with early stages of Alzheimer’s disease who meet agency criteria as well as conditions on Leqembi’s label, according to an announcement Monday by the drug’s manufacturers Eisai […]